• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丁丙诺啡和纳曲酮的联合使用可阻止啮齿动物强迫性摄入可卡因而不产生依赖性。

A combination of buprenorphine and naltrexone blocks compulsive cocaine intake in rodents without producing dependence.

机构信息

Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA 92037, USA.

出版信息

Sci Transl Med. 2012 Aug 8;4(146):146ra110. doi: 10.1126/scitranslmed.3003948.

DOI:10.1126/scitranslmed.3003948
PMID:22875830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3448552/
Abstract

Buprenorphine, a synthetic opioid that acts at both μ and κ opioid receptors, can decrease cocaine use in individuals with opioid addiction. However, the potent agonist action of buprenorphine at μ opioid receptors raises its potential for creating opioid dependence in non-opioid-dependent cocaine abusers. Here, we tested the hypothesis that a combination of buprenorphine and naltrexone (a potent μ opioid antagonist with weaker δ and κ antagonist properties) could block compulsive cocaine self-administration without producing opioid dependence. The effects of buprenorphine and various doses of naltrexone on cocaine self-administration were assessed in rats that self-administered cocaine under conditions of either short access (noncompulsive cocaine seeking) or extended access (compulsive cocaine seeking). Buprenorphine alone reproducibly decreased cocaine self-administration. Although this buprenorphine-alone effect was blocked in a dose-dependent manner by naltrexone in both the short-access and the extended-access groups, the combination of the lowest dose of naltrexone with buprenorphine blocked cocaine self-administration in the extended-access group but not in the short-access group. Rats given this low dose of naltrexone with buprenorphine did not exhibit the physical opioid withdrawal syndrome seen in rats treated with buprenorphine alone, and naltrexone at this dose did not block κ agonist-induced analgesia. The results suggest that the combination of buprenorphine and naltrexone at an appropriate dosage decreases compulsive cocaine self-administration with minimal liability to produce opioid dependence and may be useful as a treatment for cocaine addiction.

摘要

丁丙诺啡是一种合成阿片类药物,可同时作用于 μ 和 κ 阿片受体,可减少阿片类药物成瘾者的可卡因使用量。然而,丁丙诺啡对 μ 阿片受体的强烈激动作用增加了其在非阿片类依赖可卡因滥用者中产生阿片类依赖的潜力。在这里,我们测试了以下假设:丁丙诺啡和纳曲酮(一种具有较弱的 δ 和 κ 拮抗剂特性的强效 μ 阿片受体拮抗剂)的组合可以阻断强迫性可卡因自我给药,而不会产生阿片类依赖。在进行短期(非强迫性可卡因寻求)或延长(强迫性可卡因寻求)可卡因自我给药的大鼠中,评估了丁丙诺啡和各种纳曲酮剂量对可卡因自我给药的影响。丁丙诺啡单独可重复降低可卡因自我给药。尽管纳曲酮在短接触和延长接触组中以剂量依赖性方式阻断了丁丙诺啡的这种单一作用,但最低剂量的纳曲酮与丁丙诺啡的组合阻断了延长接触组中的可卡因自我给药,但未阻断短接触组。给予这种低剂量纳曲酮和丁丙诺啡的大鼠没有表现出单独给予丁丙诺啡的大鼠中出现的身体阿片类戒断综合征,并且该剂量的纳曲酮不阻断 κ 激动剂诱导的镇痛。结果表明,丁丙诺啡和纳曲酮以适当剂量联合使用可减少强迫性可卡因自我给药,而产生阿片类依赖的风险最小,可能可作为可卡因成瘾的治疗方法。

相似文献

1
A combination of buprenorphine and naltrexone blocks compulsive cocaine intake in rodents without producing dependence.丁丙诺啡和纳曲酮的联合使用可阻止啮齿动物强迫性摄入可卡因而不产生依赖性。
Sci Transl Med. 2012 Aug 8;4(146):146ra110. doi: 10.1126/scitranslmed.3003948.
2
Naltrexone and buprenorphine combination in the treatment of opioid dependence.纳曲酮与丁丙诺啡联合用于治疗阿片类物质依赖
J Psychopharmacol. 2006 Nov;20(6):806-14. doi: 10.1177/0269881106060835. Epub 2006 Jan 9.
3
An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependence.一项关于功能性阿片κ受体拮抗剂治疗阿片类药物依赖的开放标签研究。
J Subst Abuse Treat. 2000 Apr;18(3):277-81. doi: 10.1016/s0740-5472(99)00074-4.
4
The Buprenorphine Analogue BU10119 Attenuates Drug-Primed and Stress-Induced Cocaine Reinstatement in Mice.丁丙诺啡类似物 BU10119 可减弱药物激发和应激诱导的小鼠可卡因复吸。
J Pharmacol Exp Ther. 2021 Sep;378(3):287-299. doi: 10.1124/jpet.121.000524. Epub 2021 Jun 28.
5
Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study.丁丙诺啡+纳洛酮加纳曲酮治疗可卡因依赖:丁丙诺啡减少可卡因使用(CURB)研究。
Addiction. 2016 Aug;111(8):1416-27. doi: 10.1111/add.13375. Epub 2016 Apr 21.
6
Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology.丁丙诺啡减少可卡因使用(CURB):原理、设计和方法。
Contemp Clin Trials. 2013 Mar;34(2):196-204. doi: 10.1016/j.cct.2012.11.002. Epub 2012 Nov 16.
7
Naltrexone-buprenorphine interactions: effects on cocaine self-administration.纳曲酮-丁丙诺啡相互作用:对可卡因自我给药的影响。
Neuropsychopharmacology. 1993 Nov;9(3):211-24. doi: 10.1038/npp.1993.57.
8
Buprenorphine's physical dependence potential: antagonist-precipitated withdrawal in humans.丁丙诺啡的身体依赖性潜力:人类中的拮抗剂诱发戒断反应。
J Pharmacol Exp Ther. 1996 Feb;276(2):449-59.
9
Inhibition of kappa opioid receptors attenuated increased cocaine intake in rats with extended access to cocaine.抑制κ阿片受体可减轻长期接触可卡因的大鼠可卡因摄入量的增加。
Psychopharmacology (Berl). 2009 Sep;205(4):565-75. doi: 10.1007/s00213-009-1563-y. Epub 2009 May 30.
10
PPL-103: A mixed opioid partial agonist with desirable anti-cocaine properties.PPL-103:一种具有理想抗可卡因特性的混合阿片类部分激动剂。
Prog Neuropsychopharmacol Biol Psychiatry. 2022 Dec 20;119:110599. doi: 10.1016/j.pnpbp.2022.110599. Epub 2022 Jul 5.

引用本文的文献

1
Docking 14 Million Virtual Isoquinuclidines against the μ and κ Opioid Receptors Reveals Dual Antagonists-Inverse Agonists with Reduced Withdrawal Effects.针对μ和κ阿片受体对接1400万个虚拟异喹核碱,发现具有减轻戒断效应的双重拮抗剂 - 反向激动剂。
ACS Cent Sci. 2025 Apr 29;11(5):770-790. doi: 10.1021/acscentsci.5c00052. eCollection 2025 May 28.
2
Docking 14 million virtual isoquinuclidines against the mu and kappa opioid receptors reveals dual antagonists-inverse agonists with reduced withdrawal effects.将1400万个虚拟异喹核碱与μ和κ阿片受体进行对接,发现了具有降低戒断效应的双重拮抗剂-反向激动剂。
bioRxiv. 2025 Jan 14:2025.01.09.632033. doi: 10.1101/2025.01.09.632033.
3

本文引用的文献

1
Statement of the American Society Of Addiction Medicine Consensus Panel on the use of buprenorphine in office-based treatment of opioid addiction.美国成瘾医学学会共识专家组关于在基于办公室的阿片类药物成瘾治疗中使用丁丙诺啡的声明。
J Addict Med. 2011 Dec;5(4):254-63. doi: 10.1097/ADM.0b013e3182312983.
2
Buprenorphine and opioid antagonism, tolerance, and naltrexone-precipitated withdrawal.丁丙诺啡与阿片拮抗作用、耐受和纳曲酮催瘾撤药。
J Pharmacol Exp Ther. 2011 Feb;336(2):488-95. doi: 10.1124/jpet.110.173823. Epub 2010 Nov 4.
3
Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers.
Pharmacological Treatments for Cocaine Craving: What Is the Way Forward? A Systematic Review.
可卡因渴求的药物治疗:未来之路何在?一项系统评价
Brain Sci. 2022 Nov 14;12(11):1546. doi: 10.3390/brainsci12111546.
4
PPL-138 (BU10038): A bifunctional NOP/mu partial agonist that reduces cocaine self-administration in rats.PPL - 138(BU10038):一种双功能的NOP/μ部分激动剂,可减少大鼠对可卡因的自我给药行为。
Neuropharmacology. 2022 Jun 15;211:109045. doi: 10.1016/j.neuropharm.2022.109045. Epub 2022 Apr 1.
5
The Buprenorphine Analogue BU10119 Attenuates Drug-Primed and Stress-Induced Cocaine Reinstatement in Mice.丁丙诺啡类似物 BU10119 可减弱药物激发和应激诱导的小鼠可卡因复吸。
J Pharmacol Exp Ther. 2021 Sep;378(3):287-299. doi: 10.1124/jpet.121.000524. Epub 2021 Jun 28.
6
Can pharmacotherapy improve treatment outcomes in people with co-occurring major depressive and cocaine use disorders?药物治疗能否改善共病重性抑郁和可卡因使用障碍患者的治疗结局?
Expert Opin Pharmacother. 2021 Sep;22(13):1669-1683. doi: 10.1080/14656566.2021.1931684. Epub 2021 Jun 23.
7
Translational value of non-human primates in opioid research.非人类灵长类动物在阿片类药物研究中的转化价值。
Exp Neurol. 2021 Apr;338:113602. doi: 10.1016/j.expneurol.2021.113602. Epub 2021 Jan 14.
8
Improving translation of animal models of addiction and relapse by reverse translation.通过反向翻译提高成瘾和复发动物模型的翻译质量。
Nat Rev Neurosci. 2020 Nov;21(11):625-643. doi: 10.1038/s41583-020-0378-z. Epub 2020 Oct 6.
9
Animal Models of the Behavioral Symptoms of Substance Use Disorders.物质使用障碍行为症状的动物模型。
Cold Spring Harb Perspect Med. 2021 Aug 2;11(8):a040287. doi: 10.1101/cshperspect.a040287.
10
The Rise and Fall of Kappa-Opioid Receptors in Drug Abuse Research.κ-阿片受体在药物滥用研究中的兴衰
Handb Exp Pharmacol. 2020;258:147-165. doi: 10.1007/164_2019_268.
静脉注射丁丙诺啡/纳洛酮和丁丙诺啡单独用于丁丙诺啡维持的静脉注射海洛因滥用者的滥用倾向。
Addiction. 2010 Apr;105(4):709-18. doi: 10.1111/j.1360-0443.2009.02843.x.
4
The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse.内啡肽-κ 阿片系统在滥用药物强化效应中的作用。
Psychopharmacology (Berl). 2010 Jun;210(2):121-35. doi: 10.1007/s00213-010-1825-8. Epub 2010 Mar 30.
5
Inhibition of kappa opioid receptors attenuated increased cocaine intake in rats with extended access to cocaine.抑制κ阿片受体可减轻长期接触可卡因的大鼠可卡因摄入量的增加。
Psychopharmacology (Berl). 2009 Sep;205(4):565-75. doi: 10.1007/s00213-009-1563-y. Epub 2009 May 30.
6
The kappa-opioid agonist U69,593 blocks cocaine-induced enhancement of brain stimulation reward.κ-阿片受体激动剂U69,593可阻断可卡因诱导的脑刺激奖赏增强效应。
Biol Psychiatry. 2008 Dec 1;64(11):982-8. doi: 10.1016/j.biopsych.2008.05.029. Epub 2008 Jul 17.
7
A role for brain stress systems in addiction.大脑应激系统在成瘾中的作用。
Neuron. 2008 Jul 10;59(1):11-34. doi: 10.1016/j.neuron.2008.06.012.
8
Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system.应激诱导的可卡因觅求恢复由κ阿片系统介导。
Psychopharmacology (Berl). 2008 Sep;200(1):59-70. doi: 10.1007/s00213-008-1122-y. Epub 2008 Jun 25.
9
Striatal and ventral pallidum dynorphin concentrations are markedly increased in human chronic cocaine users.在慢性可卡因成瘾的人类中,纹状体和腹侧苍白球中的强啡肽浓度显著升高。
Neuropharmacology. 2008 Jul;55(1):41-6. doi: 10.1016/j.neuropharm.2008.04.019. Epub 2008 Apr 29.
10
Treatment of tobacco dependence.
Mayo Clin Proc. 2008 Apr;83(4):479-83; quiz 483-4. doi: 10.4065/83.4.479.